Skip to content
Merito
← Back to results
EB-2 NIWBiotech and pharmaIndividualDecided June 2025Dismissed

Outcome: Dismissed

JUN232025_02B5203

Merit and national importanceNot metWell positionedNot reached / not discussedBalance favors a waiverNot reached / not discussed

Our summary

A medical scientist sought EB-2 classification with national interest waiver for a biomedical research and clinical diagnostics endeavor. The AAO affirmed dismissal, holding the petitioner failed to demonstrate national importance under Dhanasar's first prong, showing only individualized benefits to clients and employees rather than broader field or regional impact.

Official PDF

Official PDF ↗

Published by USCIS. The summary is ours, in our own words; the decision text is on uscis.gov.

No criterion in the table was found met in this decision.

What was missing

  • Merit and national importance · Proposed endeavor lacks national importance; benefits limited to prospective employees and clients without broader industry or national impact.

Criteria

CriterionReadingWhy
Merit and national importanceNot metProposed endeavor lacks national importance; benefits limited to prospective employees and clients without broader industry or national impact.
Well positionedNot reached / not discussedDecision dismissed on first prong; remaining prongs not addressed.
Balance favors a waiverNot reached / not discussedDecision dismissed on first prong; remaining prongs not addressed.

A published decision describes one case. It is not legal advice and not a prediction for yours.

Similar decisions

Decisions whose text is closest to this one.